Taylor Carolyn E. 4

What Happened Carolyn E. Taylor, a director of Tonix Pharmaceuticals Holding Corp. (TNXP), was granted a derivative award of options to acquire 22,700 shares on May 12, 2026. The transaction is reported with a per-share price of $0.00 (total reported value $0) and is recorded as a grant/award rather than an open‑market purchase or sale.

Key Details

• Transaction date: 2026-05-12; Form 4 filed: 2026-05-14 (timely filing).
• Instrument: Option award (derivative) for 22,700 shares; reported price $0.00 per share.
• Vesting: Award vests on the earlier of the one‑year anniversary of the grant and the Issuer's 2027 Annual Meeting of Stockholders (per footnote).
• Shares owned after transaction: Not specified in the filing.
• No 10b5-1 plan, tax‑withholding, or sale reported in this filing.

Context This was a compensation grant (option award) under Tonix’s 2026 Stock Incentive Plan, not a market purchase or sale. Such grants are routine for directors and executives and represent potential future ownership if vested and exercised; they do not necessarily indicate immediate buying or selling sentiment.